Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chattem is a prominent consumer healthcare company headquartered in Chattanooga, Tennessee, and operates as a wholly-owned subsidiary of Sanofi. Established in 1879 as the Chattanooga Medicine Company, it has evolved into a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products, medicated skin care, and dietary supplements. The company's extensive portfolio features iconic brands such as Allegra, Gold Bond, Icy Hot, Cortizone-10, Selsun Blue, and ACT. Chattem specializes in therapeutic categories including allergy relief, topical pain management, medicated skin care, and oral hygiene. Since its acquisition by Sanofi in 2010, the company has served as the cornerstone of Sanofi's consumer healthcare presence in the North American market. Its operations include significant research, development, and manufacturing facilities dedicated to high-quality consumer health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chattem.